MK-677 Boosts Growth Hormone But Decouples Leptin from Body Fat

Leptin, a hormone primarily produced by fat cells, plays a crucial role in regulating appetite and metabolism, with its levels typically correlating directly with total body fat mass. Growth hormone secretagogues (GHSs) like MK-677 are known to increase growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels, which can influence body composition. However, the precise impact of GHSs on leptin regulation and its relationship with body fat changes has not been fully understood, particularly regarding whether the expected correlation between leptin and total body fat is maintained during MK-677 administration.

The study confirmed that MK-677 significantly elevated growth hormone and IGF-1 levels, with mean GH increasing by 2.5-fold and IGF-1 by 1.8-fold compared to placebo (p<0.001). While total body fat mass showed only a modest increase of 2.1% in the MK-677 group, serum leptin concentrations exhibited a disproportionately large increase of 43% from baseline in the active treatment group (p<0.001). This substantial rise in leptin was not mirrored by a proportional change in total body fat, indicating a significant alteration in the normal leptin-fat mass relationship. > The most striking finding was the decoupling of serum leptin levels from total body fat mass, with leptin increasing significantly more than predicted by the observed changes in body fat in subjects treated with MK-677 (p<0.005). This suggests that MK-677 may directly influence leptin secretion or metabolism independent of its effects on adiposity.